| Literature DB >> 29732080 |
Abstract
A trisubstituted chiral Cp x ligand family is introduced. Based on the disubstituted atropchiral Cp x ligand scaffold, the introduction of a bulky third substituent at the central position of the Cp ring leads to substantially increased selectivities for rhodium(iii)-catalyzed kinetic resolutions and allowed for s-factors of up to 50. Their superiority is demonstrated by kinetic resolutions of phosphinic amides providing access to compounds with stereogenic phosphorus(v) atoms. The unreacted acyclic phosphinic amide and the cyclized product are both obtained in good yields and enantioselectivities. The ligand synthesis capitalizes on a late stage modification and expands the accessible ligand Cp x ligand portfolio.Entities:
Year: 2018 PMID: 29732080 PMCID: PMC5915793 DOI: 10.1039/c7sc05411d
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Scheme 1RhIII-catalyzed desymmetrization and kinetic resolution approaches for the synthesis P-chiral compounds.
Scheme 2Kinetic resolution by a difference in the cyclometalation rates k2 > k5.
Screening of the Cp ligands for the kinetic resolution
|
| ||||||
| Entry |
|
| % Conv. | er | er |
|
| 1 |
| 8 | 54 | 91 : 9 (40) | 85 : 15 (46) | 14 |
| 2 |
| 10 | 60 | 78 : 22 (35) | 81 : 19 (46) | 4 |
| 3 |
| 32 | 30 | 63.5 : 36.5 (63) | 84 : 16 (23) | 4 |
| 4 |
| 32 | 18 | 57 : 43 (78) | 77 : 23 (17) | 5 |
| 5 |
| 32 | 54 | 68 : 32 (42) | 76 : 24 (32) | 3 |
| 6 |
| 10 | 55 | 98 : 2 (42) | 89 : 11 (48) | 32 |
| 7 |
| 8.5 | 51 | 95 : 5 (46) | 93 : 7 (46) | 42 |
| 8 |
| 5 | 55 | 98.5 : 1.5 (42) | 89 : 11 (50) | 36 |
| 9 |
| 3 | 53 | 96 : 4 (44) | 90.5 : 9.5 (48) | 32 |
| 10 |
| 3 | 55 | 99 : 1 (42) | 90.5 : 9.5 (48) | 41 |
| 11 |
| 8.5 | 52 | 97 : 3 (44) | 93 : 7 (48) | 50 |
| 12 |
| 4 | 51 | 95.5 : 4.5 (46) | 94 : 6 (46) | 47 |
Conditions: 50 μmol 1a, 75 μmol 5a, 5.0 μmol Rh7, 5.0 μmol (BzO)2, 0.10 mmol Ag2CO3, 50 μmol K2CO3, 0.25 m in tBuOH at 90 °C for the indicated time; Ar = 3,5-(CF3)C6H3.
By 1H-NMR.
By chiral HPLC, (isolated yield).
With 30 μmol 5a.
Scheme 3Synthesis of trisubstituted L6–L10 from L1.
Kinetic resolution of aryl phosphinic amides rac-1
|
| |||||||
| Entry |
| R/R′ |
| Conv. | er | er |
|
| 1 |
| H/Me | 8.5 | 51 | 95 : 5 (46) | 93 : 7 (46) | 42 |
| 2 |
| 4-Me/Me | 10.5 | 55 | 98 : 2 (42) | 89 : 11 (50) | 32 |
| 3 |
| 4-F/Me | 10.5 | 55 | 98 : 2 (40) | 90 : 10 (48) | 32 |
| 4 |
| 4-Cl/Me | 10.5 | 55 | 97 : 3 (40) | 89 : 11 (45) | 29 |
| 5 |
| 4-OMe/Me | 8.5 | 54 | 99 : 1 (42) | 91 : 9 (48) | 50 |
| 6 |
| 4-NMe2/Me | 9.5 | 42 | 83 : 17 (50) | 95 : 5 (36) | 43 |
| 7 |
| 3-Me/Me | 10.5 | 58 | 99 : 1 (38) | 85 : 15 (53) | 26 |
| 8 |
| 3-Br/Me | 14 | 55 | 99 : 1 (38) | 91 : 9 (42) | 49 |
| 9 |
| 2-Me/Me | 10 | 53 | 79 : 21 (44) | 77 : 23 (42) | 5 |
| 10 |
| H/Bn | 4 | 59 | 99.5 : 0.5 (37) | 84 : 16 (53) | 27 |
| 11 |
| H/(CH2)2OBn | 6.5 | 51 | 93 : 7 (44) | 93 : 7 (47) | 29 |
| 12 |
| H/pyrrolidinyl | 5 | 57 | 89 : 11 (40) | 79 : 21 (52) | 9 |
| 13 |
| H/morpholinyl | 3.5 | 61 | 95 : 5 (37) | 79 : 21 (55) | 11 |
| 14 |
| H/OMe | 24 | 60 | 97 : 3 (37) | 81 : 19 (55) | 15 |
| 15 |
| H/OPh | 14 | 53 | 91 : 9 (44) | 86 : 14 (48) | 16 |
Conditions: 0.10 mmol 1a, 0.15 mmol 5a, 10 μmol Rh7, 10 μmol (BzO)2, 0.20 mmol Ag2CO3, 0.10 mmol K2CO3, 0.25 m in tBuOH at 90 °C; Ar = 3,5-(CF3)C6H3.
By 1H-NMR.
By chiral HPLC, (isolated yield).
At 70 °C.
Variation of the alkyne 5
|
| |||||||
| Entry |
| R1 | R2 | Conv. | er | er |
|
| 1 |
| Ph | Ph | 51 | 95 : 5 (46) | 93 : 7 (46) | 42 |
| 2 |
| PMP | PMP | 51 | 90 : 10 (46) | 89 : 11 (46) | 18 |
| 3 |
| Bu | PMP | 50 | 94 : 6 (46) | 95 : 5 (46) | 45 |
| 4 |
| iPr | PMP | 43 | 82 : 18 (52) | 94 : 6 (37) | 23 |
| 5 |
| Bu |
| 54 | 98 : 2 (43) | 96 : 4 (48) | 39 |
Conditions: 0.10 mmol 1a, 0.15 mmol 5a–d, 10 μmol Rh7, 10 μmol (BzO)2, 0.20 mmol Ag2CO3, 0.10 mmol K2CO3, 0.25 m in tBuOH at 90 °C for 8.5 h; Ar = 3,5-(CF3)C6H3.
By 1H-NMR.
By chiral HPLC, (isolated yield).
rs = 18 : 1.
rs ≥ 20 : 1.
Scheme 4(I) Comparison of phosphinamides 2a and 8 in enantioselective reductive aldol reactions. (II) Enantiospecific reduction of 2a (2a: >99.5 : 0.5 er). (III) Rh-catalyzed asymmetric hydrogenation with 10 as chiral ligand.